News & Breakthroughs at Siteman
Stay informed with the latest cancer news and breakthroughs from Siteman Cancer Center. Our news feed provides timely updates on research breakthroughs, clinical trials, and community events.
Research
Study finds marker of aggressive prostate cancer
The level of a specific molecule present in prostate tumors is an indicator of whether the cancer is aggressive and likely to spread, according to new research from Washington University School of Medicine in St. Louis. The study, available online in the journal European Urology, may inform future clinical tests that help doctors decide how […]
Research
Study aims to find clues to breast cancer outcomes in African-American women
Scientists’ understanding of the genetic roots of breast cancer is based largely on research conducted in women of European ancestry. That knowledge does little to help explain why African-American women with the disease are more likely to be diagnosed at younger ages and with more aggressive tumors than their white counterparts. They also die of […]
In the Media, Research
Potential drug target identified for deadly brain cancer
Glioblastoma is the most common and deadly form of brain cancer in adults, with an average survival time of only 15 months after diagnosis. New research at Washington University School of Medicine in St. Louis provides clues to why some patients with glioblastoma fare worse and identifies a drug target that potentially could improve survival. […]
Staff/Faculty Update
Sasa Mutic honored as innovator
Celebrating innovation in St. Louis, the St. Louis Business Journal on June 23 honored area individuals and companies with the publication’s third annual Innovation Awards. Among those honored were Sasa Mutic, PhD, director of the Medical Physics Division in the Department of Radiation Oncology at Washington University School of Medicine. He also is a Siteman […]
Research
Tissue Procurement Core receives accreditation
The Washington University Tissue Procurement Core, which offers researchers a centralized laboratory to collect, store and use human biospecimens for translational cancer research, has received accreditation by the College of American Pathologists (CAP). The recognition is based on a recent onsite inspection, designed to ensure the highest standards for laboratory operations. “We work hand in […]
Staff/Faculty Update
Ley to receive 2016 faculty achievement award
Timothy Ley, MD, an expert in cancer genomics and leukemia, will receive a 2016 Washington University in St. Louis faculty achievement award, Chancellor Mark S. Wrighton has announced. A Siteman Cancer Center research member, Ley also is the Lewis T. and Rosalind B. Apple Professor of Medicine in the School of Medicine and chief of […]
Staff/Faculty Update
Dacey receives Cushing Medal from neurosurgery society
Ralph G. Dacey Jr., MD, has been awarded the Harvey Cushing Medal by the American Association of Neurological Surgeons (AANS). He was honored with the medal, the association’s most prestigious award, for his many years of outstanding leadership, dedication and contributions to the field of neurosurgery. The medal – named in honor of the father […]
Staff/Faculty Update
Murphy, Virgin elected to National Academy of Sciences
Two scientists at Washington University School of Medicine in St. Louis and Siteman Cancer Center are among the 84 members and 21 foreign associates elected to the National Academy of Sciences this year. Election to the academy — which was announced May 3 — is considered one of the highest honors that can be awarded […]
In the Media, Research
Treating prostate cancer with precision
The treatment, called focal needle ablation, makes use of a needle that can freeze (cryoablation) or use heat (radiofrequency ablation) to destroy cancer cells. In the past, when a biopsy—the standard diagnostic procedure for the past 20 years—detected a small amount of prostate cancer, it wasn’t known whether the cancer was small or whether the biopsy […]
Research
New clues identified in childhood cancer syndrome
Children with the inherited cancer syndrome neurofibromatosis type 1 (NF1) are prone to developing brain and nerve tumors as well as myriad other medical problems, including autism, epilepsy and bone defects. While the disorder is caused by a mutation in a single gene, the range and severity of clinical abnormalities vary widely, making the impact […]